These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20939666)

  • 1. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
    Quinteros-Muñoz D; Sáez-Briones P; Díaz-Véliz G; Mora-Gutiérrez S; Rebolledo-Fuentes M; Cassels BK
    Behav Neurosci; 2010 Oct; 124(5):662-76. PubMed ID: 20939666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques.
    Crean RD; Davis SA; Von Huben SN; Lay CC; Katner SN; Taffe MA
    Neuroscience; 2006 Oct; 142(2):515-25. PubMed ID: 16876329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2016 Sep; 27(6):497-505. PubMed ID: 27028902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors.
    Brammer MK; Gilmore DL; Matsumoto RR
    Eur J Pharmacol; 2006 Dec; 553(1-3):141-5. PubMed ID: 17070798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice.
    Ferraz-de-Paula V; Stankevicius D; Ribeiro A; Pinheiro ML; Rodrigues-Costa EC; Florio JC; Lapachinske SF; Moreau RL; Palermo-Neto J
    Braz J Med Biol Res; 2011 May; 44(5):428-37. PubMed ID: 21503414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
    Dolan SB; Chen Z; Huang R; Gatch MB
    Neuropharmacology; 2018 May; 133():171-180. PubMed ID: 29378213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.
    Murnane KS; Murai N; Howell LL; Fantegrossi WE
    J Pharmacol Exp Ther; 2009 Nov; 331(2):717-23. PubMed ID: 19684254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.
    Huang PK; Aarde SM; Angrish D; Houseknecht KL; Dickerson TJ; Taffe MA
    Drug Alcohol Depend; 2012 Nov; 126(1-2):168-75. PubMed ID: 22664136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
    Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
    Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine.
    Bullock TA; Berquist MD; Baker LE
    Behav Pharmacol; 2019 Oct; 30(7):566-573. PubMed ID: 31268871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
    Dolan SB; Forster MJ; Gatch MB
    Drug Alcohol Depend; 2017 Nov; 180():39-45. PubMed ID: 28865391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of modafinil, methamphetamine, and MDMA on agonistic behavior in male mice.
    Machalova A; Slais K; Vrskova D; Sulcova A
    Pharmacol Biochem Behav; 2012 Aug; 102(2):215-23. PubMed ID: 22579913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].
    Ross JD; Herin DV; Frankel PS; Thomas ML; Cunningham KA
    Drug Alcohol Depend; 2006 Feb; 81(2):117-27. PubMed ID: 16054778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats.
    Palenicek T; Votava M; Bubenikova V; Horacek J
    Physiol Behav; 2005 Nov; 86(4):546-53. PubMed ID: 16233904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression.
    Colussi-Mas J; Schenk S
    Eur J Neurosci; 2008 Nov; 28(9):1895-910. PubMed ID: 18973603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
    Schindler CW; Thorndike EB; Blough BE; Tella SR; Goldberg SR; Baumann MH
    Br J Pharmacol; 2014 Jan; 171(1):83-91. PubMed ID: 24328722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration.
    McNamara R; Maginn M; Harkin A
    Eur J Pharmacol; 2007 Jan; 555(2-3):194-8. PubMed ID: 17126829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.